Antibodies under a microscope

Database

Filter by:

Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity

You are searching for:

  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search

  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search

  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

3961-3970 of 4090 results

Catalogue Number:

PX-TA2089

Category:

G

Proteo Genix logo

Tobevibart Biosimilar – Anti-HBV mAb – Research Grade

Target: HBV
Target Alias Name: anti-HBV/ Hepatitis B virus enveloppe protein
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-lambda
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1030

Category:

G

Proteo Genix logo

Tocilizumab Biosimilar – Anti-IL-6R mAb – Research Grade

Target: IL-6R
Target Alias Name: Tocilizumab/IL-6R/anti-IL-6R/ Atlizumab
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1Kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1453

Category:

G

Proteo Genix logo

Tomaralimab Biosimilar – Anti-TLR2/ CD282 mAb – Research Grade

Target: TLR2/ CD282
Target Alias Name: Tomaralimab /OPN-305/TLR2/ CD282/anti-TLR2/ CD282
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG4-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1473

Category:

G

Proteo Genix logo

Tomuzotuximab Biosimilar – Anti-EGFR mAb – Research Grade

Target: EGFR
Target Alias Name: Tomuzotuximab/CetuxiMab-GEX/GEXMab52201/EGFR/anti-EGFR
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1925

Category:

G

Proteo Genix logo

Toralizumab Biosimilar – Anti-sCD40L mAb – Research Grade

Target: sCD40L
Target Alias Name: anti-sCD40L/Tumor necrosis factor ligand superfamily member 5/T-cell antigen Gp39/CD40L/TNFSF5/CD154/CD40-L/TNF-related activation protein/CD40 ligand/CD40LG/TRAP/E6040/ IDEC-131
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1540

Category:

G

Proteo Genix logo

Toripalimab Biosimilar – Anti-PDCD1/ PD1/ CD279 mAb – Research Grade

Target: PDCD1/ PD1/ CD279
Target Alias Name: Toripalimab/0/PDCD1/ PD1/ CD279/anti-PDCD1/ PD1/ CD279
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG4-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1727

Category:

G

Proteo Genix logo

Torudokimab Biosimilar – Anti-IL33 mAb – Research Grade

Target: IL33
Target Alias Name: Torudokimab/IMMUNOGLOBULIN G4 (231-PROLINE/ 237-ALANINE/ 238-ALANINE)/ ANTI-(HUMAN INTERLEUKIN 33) (HUMAN MONOCLONAL LY3375880 .GAMMA.4-CHAIN)/ DISULFIDE WITH HUMAN MONOCLONAL LY3375880 .KAPPA.-CHAIN/ DIMER/ LY-3375880/IL33/anti-IL33
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG4/Kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1324

Category:

G

Proteo Genix logo

Tosatoxumab Biosimilar – Anti-alpha toxin mAb – Research Grade

Target: alpha toxin
Target Alias Name: Tosatoxumab/KBSA301/alpha toxin/anti-alpha toxin
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-lambda
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1101

Category:

G

Proteo Genix logo

Tositumomab Biosimilar – Anti-MS4A1/ CD20 mAb – Research Grade

Target: MS4A1/ CD20
Target Alias Name: Tositumomab//MS4A1/ CD20/anti-MS4A1/ CD20
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG2a-lambda
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1328

Category:

G

Proteo Genix logo

Tovetumab Biosimilar – Anti-PDGFRA / PDGFR2/ CD140a mAb – Research Grade

Target: PDGFRA / PDGFR2/ CD140a
Target Alias Name: Tovetumab/MEDI-575/PDGFRA / PDGFR2/ CD140a/anti-PDGFRA / PDGFR2/ CD140a
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG2-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo